Gilead Sciences, Inc.
About Gilead Sciences, Inc.
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.
2098 articles with Gilead Sciences, Inc.
-
Gilead Sciences (GILD) Says Truvada Better Than Combivir For HIV
11/18/2005
-
Roche Pays Gilead Sciences (GILD) $62.5M, Royalties To End Tamiflu Dispute
11/16/2005
-
Global Epidemic
11/3/2005
-
The Day In Review: Positive Coley IPO Not Enough For Biotech
8/10/2005
-
The Day In Review: Biotech Makes Gain Before Amgen Earnings
7/19/2005
-
The Day In Review: Small Loss For Biotech
4/27/2005
-
The Day In Review: Biotech Manages To Contain Its Loss
4/20/2005
-
FHI Cancels Nigerian Arm Of Clinical Trial Testing Tenofovir For HIV Prevention
3/17/2005
-
Brazil Takes Step Toward Breaking AIDS Patents
3/16/2005
-
What Bay Area Executives Made Last Year; Genentech, Gilead
12/28/2004
-
Torre Lazur McCann Creates Consumer Group
12/3/2004
-
Drug Maker's Tight Focus Gives It An Edge
9/30/2004
-
Following The Market - Part 2
8/30/2004
-
Biotech Companies Growing, But They're Not A Panacea
8/16/2004
-
Playing The High-Stakes Biotech Game
7/8/2004
-
What's Driving Biotech
6/23/2004
-
Milberg Weiss Announces The Filing Of A Class Action Suit Against Gilead Sciences, Inc. On Behalf Of Investors
11/14/2003
-
Rebound - Gilead Sciences
11/4/2003